Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
Titel:
Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
Auteur:
Widschwendter, Martin Burnell, Matthew Fraser, Lindsay Rosenthal, Adam N. Philpott, Sue Reisel, Daniel Dubeau, Louis Cline, Mark Pan, Yang Yi, Ping-Cheng Gareth Evans, D. Jacobs, Ian J. Menon, Usha Wood, Charles E. Dougall, William C.